- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Theratechnologies Inc. (TH)
Theratechnologies Inc. stock price live, this page displays TSX TH stock exchange data. View the TH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Theratechnologies Inc. real time stock price chart below.
What Is the Theratechnologies Inc. Stock Price Today?
The Theratechnologies Inc. stock price today is 4.34.
What Is the Stock Symbol for Theratechnologies Inc.?
The stock symbol for Theratechnologies Inc. is ""TH.""
What Stock Exchange Does Theratechnologies Inc. Trade On?
Theratechnologies Inc. is listed and trades on the Toronto stock exchange.
Is Theratechnologies Inc. a Good Stock to Buy?
Determining whether Theratechnologies Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TH quote. (ISIN: CA88338H7040)
What Is the Theratechnologies Inc. Stock Price Today?
The Theratechnologies Inc. stock price today is 4.34.
What Is the Stock Symbol for Theratechnologies Inc.?
The stock symbol for Theratechnologies Inc. is ""TH.""
What Stock Exchange Does Theratechnologies Inc. Trade On?
Theratechnologies Inc. is listed and trades on the Toronto stock exchange.
Is Theratechnologies Inc. a Good Stock to Buy?
Determining whether Theratechnologies Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TH quote. (ISIN: CA88338H7040)
4.34
0.00(0.00%)
Closed·
Fair Value
An estimate of a Theratechnologies's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.33
4.35
52 wk Range
1.59
4.35
TH Scorecard
Full Analysis
High shareholder yield
Trading near 52-week High
More Info
Fair Value
An estimate of a Theratechnologies's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.334.35
52 wk Range
1.594.35
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
TH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Theratechnologies's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
7.25
Upside
+67.05%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Form 6K Theratechnologies Inc For: 9 July
- Investing.com
- Form 6K Theratechnologies Inc For: 9 July
- Investing.com
- Form 6K Theratechnologies Inc For: 3 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Theratechnologies Inc. Company Profile
Theratechnologies Inc., a biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its product pipeline includes tesamorelin F8 in HIV-associated lipodystrophy that is in Phase 2 clinical trials for the treatment of nonalcoholic steatohepatitis; SORT1+ Technology that is in Phase 1 clinical trials for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; sudocetaxel zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company also commercializes olezarsen, an RNA-targeted medicine for the treatment of familial chylomicronemia syndrome and severe hypertriglyceridemia; and donidalorsen, an RNA-targeted medicine that targets the acute attacks of hereditary angioedema. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Compare TH to Peers and Sector
Metrics to compare | TH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −15.8x | 17.9x | −0.5x | |
PEG Ratio | 3.36 | 0.02 | 0.00 | |
Price/Book | −5.2x | 5.2x | 2.6x | |
Price / LTM Sales | 1.7x | 7.5x | 3.2x | |
Upside (Analyst Target) | 67.1% | 229.3% | 41.2% | |
Fair Value Upside | Unlock | 14.7% | 6.2% | Unlock |
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 7.25
(+67.05% Upside)
Earnings
Latest Release
Jul 09, 2025
EPS / Forecast
-0.09 / 0.06
Revenue / Forecast
17.73M / --
People Also Watch
FAQ
What Stock Exchange Does Theratechnologies Trade On?
Theratechnologies is listed and trades on the Toronto Stock Exchange stock exchange.
What Is the Stock Symbol for Theratechnologies?
The stock symbol for Theratechnologies is "TH."
What Is the Theratechnologies Market Cap?
As of today, Theratechnologies market cap is 199.55M.
What Is Theratechnologies's Earnings Per Share (TTM)?
The Theratechnologies EPS (TTM) is -0.19.
From a Technical Analysis Perspective, Is TH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Theratechnologies Stock Split?
Theratechnologies has split 1 times.
How Many Employees Does Theratechnologies Have?
Theratechnologies has 103 employees.
What is the current trading status of Theratechnologies (TH)?
As of 29 Jul 2025, Theratechnologies (TH) is trading at a price of 4.34, with a previous close of 4.33. The stock has fluctuated within a day range of 4.33 to 4.35, while its 52-week range spans from 1.59 to 4.35.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.